Patents by Inventor Martin Eisman

Martin Eisman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treating peripheral atherosclerotic disease employing a cholesterol lowering drug, an ACE inhibitor, or a combination thereof
    Patent number: H1286
    Abstract: A method is provided for treating peripheral atherosclerotic disease (arteriosclerosis obliterans) and/or intermittent claudication employing a cholesterol lowering drug such as an HMG CoA reductase inhibitor alone and/or an inhibitor of the enzyme squalene synthetase and optionally a pharmaceutical which reduces serum cholesterol by a mechanism other than inhibiting production of the enzyme HMG CoA reductase or the enzyme squalene synthetase, for example, probucol or gemfibrozil; employing an ACE inhibitor alone such as captopril or ceranapril; or a combination of a cholesterol lowering drug and an ACE inhibitor.
    Type: Grant
    Filed: October 18, 1990
    Date of Patent: February 1, 1994
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Martin Eisman, Mark E. McGovern